Ron Finklestien
Finding Hidden Value in an Overlooked Tech Stock
Finding Hidden Value in an Overlooked Tech Stock
In the fast-paced world of technology, yesterday’s giants can sometimes fade from the spotlight. Yet, amidst the clamor and frenzy, eBay EBAY, the once-dominant force ...
The Intricacies of Deutsche Bank AG’s October 18th Options Trading Week
Opportunity in the Options Market As the week kicked off, investors in Deutsche Bank AG (Symbol: DB) were greeted with the availability of new ...
Gold Sees Upsurge; Velo3D Shares in Steep Descent
A cheerful sight unfolded on Wednesday as U.S. stocks enjoyed an upswing toward the end of trading, ushering in gains such as the Dow ...
The Mighty Surge of Broadcom Stock in 2024
Broadcom (AVGO) has been dominating the stock market in 2024, showing a remarkable upward trajectory of over 17% since the start of the year. ...
Analysis: Navigating the Realm of Alternative Investments in 2024
Battle of Ideas: Are Alternative Investments Relevant in 2024?
Bull vs. Bear is a weekly feature where the VettaFi writers’ room takes opposite sides to debate controversial stocks, strategies, or market ideas — ...
The Reign of the Top Dividend Kings for March 2024
Wall Street’s allure lies in dividend stocks. Research unequivocally demonstrates their superior performance compared to non-dividend counterparts. Dividend players not only generate formidable returns ...
Can CSG Systems Become A Billion Dollar Beacon In A Crowded Tech Market? Analyst Says Yes
Unlocking the Potential: CSG Systems on the Path to Billion-Dollar Valuation Analyst Bullish on CSG Systems’ Growth Potential RBC Capital Markets analyst Dan Bergstrom ...
The Environmental Impact of Congo’s Copper and Cobalt Mines
Local Communities Struggle Amidst Toxicity Residents living near Congo’s copper and cobalt mines are facing dire consequences from water contamination. Skin ailments are prevalent, ...
Merck Stock Surges on FDA Approval for Winrevair: In-Depth Market Analysis
Merck Stock Surges on FDA Approval for Winrevair: In-Depth Market Analysis
Merck & Co Inc MRK recently received regulatory approval for Winrevair (sotatercept), a revolutionary therapy for adults with pulmonary arterial hypertension (PAH). This groundbreaking ...
